Vertice Pharma Revenue and Competitors

New Providence, NJ USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Vertice Pharma's estimated annual revenue is currently $10.3M per year.(i)
  • Vertice Pharma's estimated revenue per employee is $201,000

Employee Data

  • Vertice Pharma has 51 Employees.(i)
  • Vertice Pharma grew their employee count by -4% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.6M280%N/AN/A
#2
$7.2M36-8%N/AN/A
#3
$4180M133206%$550MN/A
#4
$9.4M4742%N/AN/A
#5
$6.7M119-37%$199.6MN/A
#6
$8M40-56%N/AN/A
#7
$9.2M4628%N/AN/A
#8
$106.3M52916%N/AN/A
#9
$11.9M5916%N/AN/A
#10
$48.2M24014%N/AN/A
Add Company

Vertice Pharma is a specialty pharmaceuticals company focused on improving patients health. Vertice Pharma develops, manufactures, markets, and distributes high-quality and affordable pharmaceutical products through its operating companies. Vertice Pharma has global headquarters in the United Kingdom and United States headquarters in New Jersey.

keywords:N/A

N/A

Total Funding

51

Number of Employees

$10.3M

Revenue (est)

-4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Vertice Pharma News

2022-04-19 - Pyruvate kinase (PK) deficiency Market Size, Trends, Technological ...

Kezar Life Sciences, Momenta Pharmaceuticals, Inc, ... Teva Pharmaceutical Industries Ltd, Zydus Cadila, Vertice Pharma, Concord Biotech,...

2022-04-17 - US Sucralfate Market: Future Forecast Assessed On The Basis Of ...

Major players operating in the U.S. sucralfate market include Teva Pharmaceutical Industries Ltd., Allergan plc, Vertice Pharma LLC, and...

2022-04-06 - Clayton Pharmaceuticals and VistaPharm (a Vertice company ...

Clayton Pharmaceuticals and VistaPharm (a Vertice company) Receive FDA Approval for Sucralfate Oral Suspension...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$30.9M9527%$31.8M
#2
N/A9842%N/A
#3
$25.9M1034%N/A
#4
$27M111N/AN/A
#5
$30.8M11448%N/A